Senior insider sale
REGENERON PHARMACEUTICALS, INC. — senior position signals high conviction
$1.77M
2.26K shares
What this filing means
BASSLER BONNIE L plans to sell 2.26K shares of REGENERON PHARMACEUTICALS, INC. valued at approximately $1.77M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/7/2026ACC: 0001000275-26-000001
Director
Since Jan 2019
2.26K
Shares to sell
$1.77M
Approx. market value
1.50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
OPTION EXERCISE
CHECK
1/7/2026
1.50KTotal acquired1.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/7/2026 | OPTION EXERCISE CHECK | 1.50K | — |
| Total | 1.50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
760.00
Market value
$570.0K
11/20/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.50K
Market value
$1.20M
1/7/2026
Total
Units
2.26K
Value
$1.77M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/20/2025 | 760.00 | $570.0K | — | Completed |
| Planned — Approximate Date | ||||
1/7/2026 | 1.50K | $1.20M | NASDAQ | Planned |
| Total | 2.26K | $1.77M | ||